Current stock page

Catalysts

BBNX Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DevicesScore data as of Nov 18, 2026

BBNXBeta Bionics, Inc.

Healthcare / Medical - Devices

Low Priority

In Line With Peers

NeutralEdge 5/10
$14.33−$0.39 (−2.65%)

Latest quote

  • Momentum
    72
  • Value
    39
  • Quality
    53
  • Risk resilience
    36
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 16, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 54/100

Momentum 72/100 and sentiment — before the next covered event.

Recent coverage
0 articles

Updated — · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 72/100AIQ Edge 5/10 In Line With Peers
Beat rate
75%
6 of 8 reported periods
Average surprise
-29.9%
Across covered historical reports
Latest result
+0.6%
Oct 27, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 27, 2026—-$0.52-$0.52+0.6%$34.72M$35.51M
Jul 29, 2026—-$0.58-$0.53+8.8%$31.46M$32.01M
Apr 21, 2026—-$0.53-$0.49+7.5%$26.95M$27.63M
Feb 17, 2026—-$0.42-$0.30+28.6%$30.39M$32.12M
Oct 28, 2025—-$0.45-$0.33+26.7%$28.91M$27.25M
Jul 29, 2025—-$0.51-$0.39+23.5%$21.9M$23.24M
May 6, 2025—-$0.51-$0.52-2.0%$16.15M$17.64M
Mar 25, 2025—-$0.42-$1.82-333.3%$20.19M$20.44M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
11
Buy
4
Hold
12-month analyst target
$24.60
+71.67% versus current price
Based on 15 analyst observations. Targets are estimates, not predictions.
Low target
$16.00
+11.65% vs latest price
Average target
$24.60
+71.67% vs latest price
High target
$30.00
+109.35% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 16, 2027

Next known earnings or reporting date.

EPS estimate-$0.50

Current analyst expectation for the upcoming report.

Revenue estimate$30.42M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score72

Where event reaction would show up first.

AIQ score54/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
15
Average target
$24.60
Target upside
71.67%
Target range
$16.00 - $30.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

BBNX Catalysts FAQ

What are the next catalysts for BBNX stock?

BBNX's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move BBNX stock?

Upcoming events that could move BBNX include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could BBNX's next earnings report affect the stock?

BBNX's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive BBNX stock higher?

BBNX could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt BBNX stock?

BBNX could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.